Covaderm Dressing: Uses, Types, and HCPCS Codes

Medical disclaimer: This guide provides technical specifications, regulatory classifications, and supply details for clinical research personnel and healthcare procurement staff. It does not provide individual medical advice, clinical diagnoses, or procedural instructions.

Short Answer

Covaderm is a brand of multi-layered adhesive composite wound dressings manufactured by DeRoyal Industries. It combines a protective non-adherent wound contact layer, an absorbent central pad, and a conformable adhesive fabric border, with select models adding a semi-occlusive polyurethane barrier film. Facilities deploy Covaderm for surgical incisions, superficial trauma, and chronic exuding wounds under HCPCS billing codes A6203 and A6204.

Definition and Scope

Covaderm encompasses an integrated line of sterile, single-use adhesive wound dressings designed to replace separate gauze pads, medical tape, and scissors with a single pre-assembled unit. Within regulatory and supply systems, Covaderm occupies two distinct medical supply designations based on barrier film construction:

Composite Dressings (Covaderm Plus and Covaderm Plus Thin): The Centers for Medicare & Medicaid Services (CMS) define a composite dressing under DME Policy Article A54563 as combining a non-chemical physical bacterial barrier across the pad and border, an absorptive layer other than alginate or foam, and a non-adherent wound contact layer. These configurations bill under HCPCS codes A6203 and A6204.
Specialty Absorptive and Island Dressings (Standard Covaderm and Covaderm Thin): Configurations lacking the polyurethane film serve as breathable absorbent covers. CMS designates these as specialty absorptive or island dressings, billing under HCPCS codes A6254, A6255, A6219, or A6220 based on pad dimensions.

Under FDA classifications, Covaderm dressings fall under 21 CFR 880.5240 (Medical adhesive tape and adhesive bandage) as Class I medical devices under product code KGX. Class I devices in this category are subject to general controls and exempt from 510(k) premarket notification under 21 CFR 880.9. Regulatory histories across device lines can be referenced in the openFDA device classification database.

How It Works or How It Is Used in Practice

Covaderm supports moist wound healing while providing mechanical protection and exudate control. In clinical practice, the dressing serves either as a primary dressing directly covering the wound bed or as a secondary protective cover over primary cavity fillers or topical treatments.

Four-Layer Architecture

The protective action of Covaderm Plus relies on four functional layers:

Non-Adherent Contact Layer: A porous mesh in direct contact with the wound allows exudate to pass freely into the core while preventing healing tissue, sutures, or staples from adhering to the dressing, minimizing trauma during removal.
Absorbent Core Pad: A soft cellulosic pad absorbs and locks in wound drainage, shielding the periwound skin from maceration while sustaining the moist environment necessary for epithelialization.
Polyurethane Barrier Film: Featured in Covaderm Plus models, this semi-occlusive layer acts as an impermeable barrier against external fluids and microorganisms while maintaining moisture vapor transmission.
Adhesive Fabric Tape Border: An elastic woven fabric coated with hypoallergenic adhesive conforms securely to body contours. Rounded corners prevent edge-rolling, and a split release liner allows one-step sterile application.

Clinical Indications

Per DeRoyal Instructions for Use (IFU Document 4-7074G), Covaderm is indicated for over-the-counter care of minor abrasions, cuts, and minor scalds. Under licensed practitioner supervision, indications include:

Surgical incision sites, including laparotomy, arthroscopic, and caesarean incisions.
Dermal ulcers, including pressure injuries, venous leg ulcers, and diabetic ulcers.
Superficial and partial-thickness second-degree burns.
Skin graft donor and harvest sites.
Catheter exit sites and drainage tubes via radial-slit configurations.

The Covaderm product family consists of several specialized tiers tailored to wound depth, drainage volume, and anatomical location.

Product Tier	Construction Details	Polyurethane Film	Exudate Level	HCPCS Codes
Covaderm Plus	Four-layer composite with rounded fabric border	Yes	Moderate to heavy	A6203 (pad ≤ 16 sq in); A6204 (pad 16.1–48 sq in)
Covaderm Plus Thin	Low-profile four-layer composite for contours	Yes	Light to moderate	A6203 (pad ≤ 16 sq in); A6204 (pad 16.1–48 sq in)
Covaderm Plus V.A.D.	Composite with radial slit and extra V-tape strip	Yes	Catheter and tube sites	A6203 (4" × 4" dressing)
Covaderm Standard	Three-layer island dressing without barrier film	No	Light to moderate	A6254 (pad ≤ 16 sq in); A6255 (pad 16.1–48 sq in)
Covaderm Thin	Low-profile island dressing in bulk case packaging	No	Light drainage	A6219 (pad ≤ 16 sq in); A6220 (pad 16.1–48 sq in)

In clinical supply management, Covaderm is frequently evaluated alongside other dressing modalities. High-exudate or fragile wound beds may warrant silicone foam wound dressings to reduce shear stress. Non-bordered packing pads are typically held in place using roller gauze. Prior to dressing application, clinicians routinely irrigate the site with Puracyn wound cleanser or apply physical bacterial-binding Sorbact dressings to manage bioburden.

Where It Matters for Labs, Clinics or Supply Decisions

Standardizing Covaderm within hospital formularies, surgical centers, and research trial sites requires attention to environmental, regulatory, and billing criteria.

Storage and Handling

Manufacturer IFU guidelines dictate storing Covaderm dressings at controlled room temperature, shielded from excessive heat and direct humidity. Extreme storage temperatures can degrade adhesive polymers, impairing skin adhesion, while humid environments threaten sterile packaging seals.

Medicare DME Coverage Criteria

Under Medicare DME MAC Local Coverage Determination (LCD) L33831, reimbursement for composite dressings (A6203/A6204) requires documentation satisfying specific criteria:

Qualifying Wound: The wound must result from a surgical procedure or professional debridement.
Exudate Justification: Covered specifically for wounds with moderate to heavy drainage; billing composites on dry wounds fails medical necessity.
Change Frequency: Standard coverage permits up to three dressing changes per week (one dressing per change), unless clinical documentation substantiates heavier exudate.

Clinical Trial Sourcing

For clinical trial protocols tracking incision recovery or topical therapeutics, Covaderm offers standardized coverage without natural rubber latex, eliminating latex sensitivity as a study variable. Lot numbers and sterility expiration dates printed on each package facilitate traceability across multi-center trials.

Common Misunderstandings

Assuming All Covaderm Models Are Waterproof: Only Covaderm Plus and Covaderm Plus Thin incorporate the water-resistant polyurethane barrier film. Standard Covaderm models feature breathable fabric backings that permit moisture penetration.
Misapplying HCPCS Codes: Billing standard Covaderm as A6203 is improper because it lacks the required composite barrier film. Standard models must be coded under A6254 or A6255.
Reprocessing Single-Use Devices: Covaderm dressings are strictly single-use. Re-sterilization or washing damages adhesive properties, alters membrane porosity, and risks clinical contamination.
Applying to Contraindicated Wounds: Covaderm is contraindicated for third-degree burns, heavily bleeding wounds requiring active hemostasis, and individuals with known adhesive allergies.

Frequently Asked Questions

Is Covaderm Plus waterproof?

Covaderm Plus incorporates a semi-occlusive polyurethane barrier film that resists water and external fluids, allowing light showering when edges are securely sealed. Standard Covaderm lacks this barrier film and is water-permeable.

Does Covaderm contain natural rubber latex?

No. DeRoyal Covaderm dressings are labeled as not made with natural rubber latex, minimizing hypersensitivity risks in clinical and research settings.

What is the difference between Covaderm and Covaderm Plus?

Covaderm Plus includes a semi-occlusive polyurethane film providing fluid and bacterial barrier protection, categorized as a composite dressing (HCPCS A6203/A6204). Standard Covaderm lacks this film and is classified as a specialty absorptive dressing (HCPCS A6254/A6255).

What is the standard change frequency for Covaderm?

Dressings should be changed when saturated, when strike-through occurs, or as directed by a clinician. Medicare DME guidelines cover composite dressings for up to three changes per week.

Sources

DeRoyal Industries, Inc. (2016). Covaderm Family Instructions for Use (IFU) (Document Part # 4-7074G, Rev. 2016). Powell, TN. Retrieved November 9, 2026, from https://www.deroyal.com/docs/default-source/product-literature/4-7074g-covaderm-ifu-(20-5×10-25)-ce-ifu-2016.pdf?sfvrsn=4f188977_4
DeRoyal Industries, Inc. (2015). Covaderm Family Literature & Specifications (Reprint # 0-1553, Rev. 07/15). Powell, TN. Retrieved November 9, 2026, from https://www.deroyal.com/docs/default-source/product-literature/0-1553-covaderm-family-literature-web.pdf?sfvrsn=d69ab9d9_4
Centers for Medicare & Medicaid Services (CMS). (2024). Local Coverage Determination (LCD): Surgical Dressings (L33831). DME MAC Jurisdictions A, B, C, D. Retrieved November 9, 2026, from https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=33831
Centers for Medicare & Medicaid Services (CMS). (2024). Billing and Coding: Surgical Dressings (A54563). DME MAC Jurisdictions A, B, C, D. Retrieved November 9, 2026, from https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=54563
United States Food and Drug Administration (FDA). (2024). 21 CFR 880.5240: Medical adhesive tape and adhesive bandage. Title 21 – Food and Drugs, Chapter I, Subchapter H – Medical Devices. Retrieved November 9, 2026, from https://www.law.cornell.edu/cfr/text/21/880.5240